SHC Earnings Date: Nov 3, 2026 (Estimated) — Sotera Health Company
NASDAQ · Healthcare · Diagnostics & Research
Updated
When is SHC's next earnings date?
Sotera Health Company (SHC) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.27 on revenue of $319.9M.
How did SHC do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Sotera Health Company posted EPS of $0.26 versus the $0.24 estimate, a beat of 8.3%. Revenue was $321.4M against a $309.7M estimate. The stock's 1-day post-earnings move was +5.2%.
How much does SHC stock move after earnings?
SHC beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.4% (up or down) in the day after earnings.
About Sotera Health Company
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | 0.24 | 0.26 | +8.33% | $321.4M | ✅ Beat | +5.17% | +5.06% | +5.84% |
| 2026-05-05 | Q1 2026 | 0.17 | 0.18 | +5.88% | $280.0M | ✅ Beat | -0.39% | +0.26% | -0.78% |
| 2026-02-24 | Q4 2025 | 0.23 | 0.26 | +13.04% | $303.4M | ✅ Beat | -4.40% | -9.03% | -20.90% |
| 2025-11-04 | Q3 2025 | 0.21 | 0.26 | +23.81% | $311.3M | ✅ Beat | -1.08% | -5.24% | +1.38% |
| 2025-08-08 | Q2 2025 | 0.16 | 0.20 | +25.00% | $294.3M | ✅ Beat | +24.51% | +40.46% | +41.80% |
| 2025-02-27 | Q4 2024 | 0.20 | 0.21 | +5.00% | $290.2M | ✅ Beat | -9.97% | -13.34% | -13.49% |
| 2024-11-05 | Q3 2024 | 0.18 | 0.17 | -5.56% | $285.5M | ❌ Miss | -2.41% | +0.76% | -15.95% |
| 2024-05-02 | Q1 2024 | 0.12 | 0.13 | +8.33% | $248.2M | ✅ Beat | -3.19% | -0.49% | -0.80% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $321.4M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Service | 86.6% | $278.3M | +8.2% | $238.8M | $223.9M | $257.2M | $255.5M |
| Product | 13.4% | $43.0M | +16.0% | $51.4M | $30.6M | $37.1M | $55.8M |
By region
FY2025 · $1.16B total · annual
| Segment | Share | Revenue | YoY | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 54.1% | $629.5M | +2.1% | $579.0M | $591.0M | $616.7M | $629.5M |
| Europe | 20.0% | $232.2M | +18.5% | $166.0M | $187.5M | $196.0M | $232.2M |
| CANADA | 19.1% | $221.9M | +6.3% | $188.7M | $192.1M | $208.9M | $221.9M |
| Other Geographical Areas | 6.9% | $79.9M | +1.4% | $69.9M | $78.7M | $78.9M | $79.9M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.